Testing a bladder transplant done with a kidney transplant
Part of Brain & nervous system, Genetic & congenital, Kidney & urinary, Women’s health & pregnancy clinical trials.
This early-phase study is testing a combined bladder and kidney transplant approach for people whose bladder problems damage the kidneys. The goal is to see if this treatment can improve bladder and kidney outcomes and be done safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 1 and 60 years old
- You need a bladder transplant because of severe bladder pressure/leaks or bladder overactivity causing kidney problems
- If getting a kidney transplant too, your kidney function is low (GFR about 20 or less) or you’re on dialysis
- You can learn and follow bladder care training, such as clean intermittent catheterization (CIC) and bladder “cycling”
- You must be approved by the Mayo Clinic kidney and transplant team, including a psychological readiness check
- You must avoid pregnancy for 1 year after surgery (for female participants, only if applicable)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines how long you've been on dialysis and how much urine you still produce might affect your bladder's ability to hold and stretch after a kidney transplant. Understanding this helps doctors predict how well your bladder will work after you receive a new kidney.
This trial offers a first-in-human transplant of a bladder or a kidney combined with a bladder from a deceased donor. It is for people with severe bladder problems or bladder cancer who already need a new bladder or are on immune-suppressing medicines for a prior organ transplant.
This study looks at whether a special X-ray test of the bladder and urethra before a living-donor kidney transplant can help predict how well the transplant works. It aims to find problems early so patients can get better care.
This early-phase trial tests a stem cell transplant from a donor who is an extremely close match, given to people who are about to receive a kidney transplant from the same donor. The goal is to improve how well the new kidney works by resetting the immune system to better accept the transplant.
This study tests whether giving a special mix of donor immune cells along with immune-suppressing medicines right after a kidney transplant can help the body accept the new kidney without long-term anti-rejection drugs. It aims to reduce the need for daily transplant medications.
This study looks at whether a stem cell transplant (AHSCT) can improve bladder problems and quality of life in people with multiple sclerosis (MS). It compares people getting this treatment with those on standard MS therapy.
Hear when a new Bladder Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.